High Growth Tech Stocks To Explore In November 2024 [Yahoo! Finance]
TG Therapeutics, Inc. (TGTX)
Last tg therapeutics, inc. earnings: 11/12 07:34 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.tgtherapeutics.com
Company Research
Source: Yahoo! Finance
and Russell 2000 showing impressive gains driven by expectations of policy changes that could spur economic growth. As investors navigate these dynamic conditions, high-growth tech stocks present intriguing opportunities, especially those well-positioned to benefit from potential regulatory easing and tax reforms. Name Revenue Growth Earnings Growth Growth Rating Material Group ?????? Scandion Oncology ?????? TG Therapeutics ?????? Pharma Mar ?????? Sarepta Therapeutics ?????? Alkami Technology ?????? Alnylam Pharmaceuticals ?????? Adveritas ?????? Travere Therapeutics ?????? UTI ?????? Click here to see the full list of 1283 stocks from our High Growth Tech and AI Stocks screener. Let's dive into some prime choices out of from the screener. Simply Wall St Growth Rating: ?????? Overview: Kexing Biopharm Co., Ltd. focuses on the research, development, production, and sale of recombinant protein drugs and microbial preparations bot
Show less
Read more
Impact Snapshot
Event Time:
TGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TGTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TGTX alerts
High impacting TG Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TGTX
News
- TG Therapeutics, Inc. (NASDAQ: TGTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.MarketBeat
- TG Therapeutics says 2024 Briumvi sales topped expectations [Seeking Alpha]Seeking Alpha
- TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones [Yahoo! Finance]Yahoo! Finance
- TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development MilestonesGlobeNewswire
TGTX
Earnings
- 11/4/24 - Miss
TGTX
Sec Filings
- 1/30/25 - Form 4
- 1/30/25 - Form 4
- 1/14/25 - Form 8-K
- TGTX's page on the SEC website